NFKB1 and cryptosporidiosis: In vivo experiments preliminarily verified that oxymatrine can control intestinal inflammation by regulating the TNF/NF-κB signaling pathway and down-regulating the expression of TNF-α, NF-κB, and IL-6, thereby contributing to the treatment of cryptosporidiosis.